195 related articles for article (PubMed ID: 7124037)
21. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
[TBL] [Abstract][Full Text] [Related]
22. Relationship of lipid disorders to coronary heart disease.
Glueck CJ
Am J Med; 1983 May; 74(5A):10-4. PubMed ID: 6846376
[TBL] [Abstract][Full Text] [Related]
23. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
[TBL] [Abstract][Full Text] [Related]
25. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
[TBL] [Abstract][Full Text] [Related]
26. [Changes in serum lipoproteins in patients with ischemic heart disease at an early age].
Malamov E; Kiriakov A; Tsenov I; Kavrukova Iu; Kusitasev G
Vutr Boles; 1982; 21(2):91-8. PubMed ID: 7101895
[TBL] [Abstract][Full Text] [Related]
27. [Screening and therapy control of lipid metabolism disturbances in general practice (author's transl)].
Assmann G; Schriewer H
MMW Munch Med Wochenschr; 1980 Mar; 122(13):449-52. PubMed ID: 6769013
[TBL] [Abstract][Full Text] [Related]
28. [Correlation between dyslipoproteinemia and coronary risk. Therapeutic effect of essential phospholipids on LDL/HDL].
Diamantopoulos EJ; Varsou L
Med Welt; 1979; 30(48):1827-32. PubMed ID: 230406
[No Abstract] [Full Text] [Related]
29. Serum lipid profile in children of coronary heart disease patients.
Ali W; Bandh A; Ul Hassan M
Indian J Physiol Pharmacol; 1995 Jul; 39(3):287-9. PubMed ID: 8550128
[TBL] [Abstract][Full Text] [Related]
30. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
31. Lipid abnormalities in coronary heart disease: a population-based case-control study.
Gupta R; Kaul V; Prakash H; Sarna M; Singhal S; Gupta VP
Indian Heart J; 2001; 53(3):332-6. PubMed ID: 11516034
[TBL] [Abstract][Full Text] [Related]
32. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
Ferlito S; La Spina E; Cultrera E; Puleo F; Carrà G
Arch Sci Med (Torino); 1982; 139(2):175-81. PubMed ID: 7138283
[TBL] [Abstract][Full Text] [Related]
33. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
34. Distribution of cholesterol in HDL and its subfractions in patients with coronary atherosclerotic heart disease.
Jayakumari N; Raghu K; Kumari VA; Balakrishnan KG; Iyer KS
Indian Heart J; 1993; 45(4):265-8. PubMed ID: 8138276
[TBL] [Abstract][Full Text] [Related]
35. Serum lipoproteins in patients with clinical signs of atherosclerosis: peripheral vascular and coronary heart disease.
Kaliman J; Widhalm K; Strobl W
Artery; 1980; 8(6):547-52. PubMed ID: 7259533
[TBL] [Abstract][Full Text] [Related]
36. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
37. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
[TBL] [Abstract][Full Text] [Related]
38. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease.
Agoşton-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(4):341-7. PubMed ID: 18767409
[TBL] [Abstract][Full Text] [Related]
40. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
